ScholarWorks@Korea University: Lee, Heon Jeong

Detailed Information

Lee, Heon Jeong (이헌정)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 02-920-6721
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Polymorphism:19||Bipolar disorder:16||Restless legs syndrome:9||polymorphism:9||Major depressive disorder:8||Schizophrenia:8||Depression:7||schizophrenia:6||circadian rhythm:6||Circadian rhythm:6||Tardive dyskinesia:6||Sleep:6||mood disorder:5||restless legs syndrome:5||.:5||wearable device:4||Panic disorder:4||Anxiety:4||Quality of life:4||Brainderived neurotrophic factor:4||antipsychotics:4||machine learning:4||Morningness:3||digital therapeutics:3||Mood disorder:3||olanzapine:3||Oxidative stress:3||Antipsychotics:3||digital phenotype:3||insomnia:3||Diurnal preference:3||Chronotype:3||Interleukin10:2||Association:2||Korean:2||Seasonal affective disorder:2||ARNTL:2||amisulpride:2||virtual reality:2||cognitive behavioral therapy:2||DRD3 gene:2||Childhood maltreatment:2||Olanzapine:2||sleep duration:2||obesity:2||bipolar disorder:2||CLOCK gene:2||Suicide:2||Cytokine:2||ANK3:2||Validity:2||CLOCK:2||Rome III:2||Liver injury:2||Genomewide association study:2||UTRN:2||Insomnia:2||seasonality:2||Actigraphy:2||Functional dyspepsia:2||Duloxetine:2||weight gain:2||Stress:2||GNB3:2||Geneenvironment interaction:2||Cohort study:2||seasonal affective disorder:2||Delayed sleep phase syndrome:2||fMRI:2||Neurotrophin:2||Cortisol:2||Polysomnography:2||haplotype analysis:2||Obstructive sleep apnea:2||Circadian dysregulation:2||Biological rhythm:2||HTR2A:1||Donor:1||hair follicle:1||Antidepressant:1||Electroconvulsive therapy:1||Circadian disruption:1||Validation:1||ESIMS:1||REM sleep:1||Artificial light:1||Anxiety sensitivity:1||suicide:1||climate factor:1||telemedicine:1||glutamatergic synapse:1||circadian clock prediction model:1||Fitbit:1||brain activation:1||light exposure:1||Sleep efficiency:1||Hypersomnia:1||Functional enrichment pathway analysis:1||GABA:1||IL17:1||Immune:1||Genomewide association:1||아미설프라이드:1||RLS · Schizophrenia · RORA · Genetic polymorphism · Circadian rhythm.:1||Val66Met polymorphism:1||genegene interaction:1||polymorphism:1||Therapeutic response:1||Tryptophan hydroxylase 2:1||Fitness trackers:1||Impulsivity:1||mobile phone:1||intervention:1||Human saliva:1||Cohort:1||prediction:1||Heart rate:1||Circadian restactivity rhythm:1||Early mood disorders:1||genomewide association study:1||sleep health:1||longacting injectable antipsychotics:1||MEIS1 gene:1||BHLHE40:1||Th17 cell:1||Polymorphisms:1||조현병:1||Delayed sleep phase disorder:1||Functional gastrointestinal disorder:1||Rome III criteria:1||Antipsychotic:1||Tyrosine hydroxylase:1||periodic limb movements during sleep:1||5HT2C receptor:1||rifampin:1||VR:1||Life style:1||Benzodiazepine:1||Eveningness:1||executive function:1||hidden Markov model:1||recurrent neural network:1||digital healthcare:1||anxiety:1||questionnaires:1||Circadian clock:1||Epworth sleepiness scale:1||Modification:1||Sociocultural lifestyle:1||Dim light at night:1||response inhibition:1||NIRS:1||Occupational stress:1||Childhood trauma:1||Depressive symptom:1||Comparison:1||mobile application:1||microRNA:1||miR19085p:1||replication study:1||Firstnight effect:1||Mood stabilizer:1||RORC:1||Prognosis:1||sleep apnea syndrome:1||Insulinlike growth factor1:1||IL23:1||지연성 운동이상증:1||hyperprolactinemia:1||Circadian rhythm questionnaire:1||Hepatotoxicity:1||Irritable bowel syndrome:1||G protein:1||Weight gain:1||Mirtazapine:1||glutathione Stransferase:1||Antipsychotics·Adverse effect·Hyperprolactinemia·Prolactin:1||Tryptophan hydroxylase:1||cytochrome P450 3A (CYP3A):1||Pglycoprotein:1||unctional magnetic resonance imaging:1||validation:1||clinical symptoms:1||random forest:1||social anxiety disorder:1||wearable activity tracker:1||highsensitivity Creactive protein:1||circadian genes:1||circadian time estimation:1||Localized surface plasmon resonance:1||Seasonality:1||MAP2K5:1||Haplotype:1||Mental health:1||Retinoid acid receptorrelated orphan receptor alpha (RORA) gene:1||Utrophin:1||CACNA1C:1||dim light at night:1||chronotype:1||REM:1||sleep:1||atypical antipsychotics:1||paliperidone palmitate:1||NPAS2:1||DRD2 gene:1||Suicide rate:1||NFIL3:1||Alcohol Use Disorders Identification Test:1||Nerve growth factor:1||Interferon gamma:1||Agoraphobia:1||Seasonal pattern:1||TNFα:1||Genetic polymorphism:1||유전적 다형성.:1||delirium:1||DRS:1||sterol regulatory elementbinding protein:1||peroxisome proliferatoractivated receptoralpha:1||Epidemiology:1||Bupropion:1||9hydroxyrisperidone:1||mood disorders:1||young adult:1||social anxiety:1||exposure therapy:1||eveningness:1||circadian preference:1||5HTTLPR:1||hyperactivity disorder:1||potential effectiveness:1||mobile appbased cognitive behavioral therapy for insomnia:1||Kidney transplantation:1||Aptasensor:1||Bright light:1||Visuohaptic:1||Virtual reality:1||LC:1||major depressive disorder subjects:1||metabolites:1||Hematological features:1||Bipolar disorders:1||circadian clock gene:1||Awakening:1||dim artificial light at night:1||Medication Satisfaction Questionnaire:1||Gene:1||Bipolar depression:1||Non24 hour sleepwake disorder:1||G protein beta 3:1||Single nucleotide polymorphisms:1||Tumor necrosis factoralpha:1||Gray matter:1||MDAS:1||paliperidone:1||5HT1A receptor:1||treatment response:1||Harm avoidance:1||Pregabalin:1||Weight:1||항정신병약물·부작용·고프로락틴혈증·프로락틴:1||ADHD:1||drug interaction:1||Cluster analysis:1||episode prediction:1||Mathematical modelling:1||Lurasidone:1||Randomized clinical trial:1||Psychology:1||smartphone app:1||weekend catchup sleep:1||Gold nanoparticles:1||Multimodal feedback:1||frontal lobe function:1||Pittsburgh sleep quality index:1||WHOQOLBREF:1||solar radiation:1||Phase shift:1||bipolarity:1||snoring:1||polysomnography:1||NET gene:1||Personality characteristics:1||Serotonin 1A receptor:1||Treatment:1||Altitude:1||SLC6A2:1||children:1||Tramadol:1||Koreans:1||Pharmacogenetics:1||Amisulpride:1||치료반응:1||유전자:1||하지불안증후군·조현병·RORA·유전자 다형성·하루주기리듬.:1||prolactin:1||Gender:1||Comorbidity:1||adenosine 5 'monophosphateactivated protein kinase:1||monoamine A and B genes:1||Serotonin transporter:1||Genderdependent effect:1||tardive dyskinesia:1||seasonal variation:1||type 2:1||adjunctive treatment:1||Causality:1||Safety:1||mental health:1||effectiveness:1||Recipient:1||inflammation:1||Circadian:1||Sleep deprivation:1||Ketamine:1||projections and predictions:1||Male and Female:1||BRIAN:1||Korean version:1||escitalopram:1||MS:1||Sex:1||Replication study:1||Wearable activity tracker:1||cortisol:1||circadian gene:1||Review:1||Artificial light at night:1||Sleep irregularity:1||PER2:1||Treatment Satisfaction Questionnaire for Medication:1||Single nucleotide polymorphism:1||Upper airway resistance syndrome:1||rs1800497:1||neurocognitive function:1||Adverse effect:1||Withdrawal symptoms:1||Alcohol dependence:1||Lesch type I:1||Prefrontal cortex:1||Serotonin receptor 3A gene:1||rs6280.:1||도파민D3 수용체:1||유전자다형성:1||rs6280:1||Atypical feature:1||cannabinoid receptor:1||Tyrosine hydoxylase:1||Neurodevelopment:1||risperidone:1||questionnaire:1||Diabetes mellitus:1||Suicide attempt:1||Psychological association:1||recurrence prevention:1||Before bedtime:1||plasma:1||Melatonin:1||Genetic association:1||Dentist:1||Daytime sleepiness:1||MDCRC:1||working memory:1||negative symptom treatment response:1||rs1079597:1||Socioeconomic status:1||South Korea:1||asthma:1||Voxelbased morphometry:1||BTBD9 gene:1||Treatment response:1||종양괴사인자알파(TNFα):1||brainderived neurotrophic factor:1||gene polymorphisms:1||major depression:1||mirtazapine:1||Hepatic dysfunction:1||irritable bowel syndrome:1||GlutathioneStransferase:1||Prevalence:1||Stressor:1||BDNF:1||Serotonin 2A receptor:1||social phobia:1||Mediation:1||Glycemic control:1||Dementia:1||attentiondeficit:1||feasibility:1||Survival analysis:1||Efficacy:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE